Abstract
Background Healthcare providers can use these virtual platforms for delivering medical advice and prescriptions of medications to patients. This study was aimed to explore the patient’s experiences and level of satisfaction regarding virtual health care received during the COVID-19 pandemic. This study also assessed the before and during lockdown sleep quality in these participants.
Design and Methods The current study included 522 participants from Saudi Arabia. Virtual healthcare satisfaction questionnaire was implemented to record the data on patient experience toward the virtual health care during COVID-19 pandemic.
Results Patients’ opinions regarding virtual health care received during the COVID-19 pandemic era are summarized using the “five-point Likert scale”. The mean score of all the five statements is 4.15, reflecting 83% level of satisfaction of participants towards virtual health care. Among participants, mostly agreed that they were able to communicate adequately with doctors, the picture and sound quality of the virtual appointment were good, their privacy was respected during the consultation, they were comfortable during history taking and exams that were done, and the doctor explained solutions including prescribing medicine and/or providing advice. However, there was no significant association found between the type of specialty attended or patient demographic factors and level of satisfaction. Results of subjective sleep parameters assessed before and during lock down are depicted. Results of t-test showed that the mean scores of all the components namely sleep duration (P<0.001); sleep disturbances (P<0.001), sleep latency (P<0.001), daytime dysfunction (P<0.001), habitual sleep efficiency (P<0.001), and subjective sleep quality (P<0.001) significantly differed between two assessment levels. Mean scores of all the components shifted towards higher values, representing worsening of sleep quality during the COVID-19 pandemic lock down.
Conclusions Findings support and conclude that virtual health care system can be adopted in clinical settings.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Current study was approved (Approval No.: ECM#2020-1002) by the Research Ethics Committee, King Khalid University, Saudi Arabia on 19/08/2020.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Ayed A. Shati shatiayed{at}gmail.com, ashati{at}kku.edu.sa, Hasan S. Alamri Hsalamri{at}kku.edu.sa, Abdulaziz M. Al-Garni amoalqarni{at}kku.edu.sa, Syed E. Mahmood semahmood{at}gmail.com, Awad S. Alsamghan asoman{at}kku.edu.sa
Data Availability
If the data are all contained within the manuscript and/or Supporting Information files, enter the following: All relevant data are within the manuscript and its Supporting Information files.
